Update glede
Instead of FDA’s Requested 500 Pages Per Month, Court Orders FDA to Produce Pfizer Covid-19 Data at Rate of 55,000 Pages Per Month!
https://aaronsiri.substack.com/p/instead-of-fdas-requested-500-pages
Zavlačenje se je začelo
The FDA "has now asked the Court to make the public wait until May for it to start producing 55,000 pages per month"...
beckernews.com
The FDA “has now asked the Court to make the public wait until May for it to start producing 55,000 pages per month and, even then, claims it may not be able to meet this rate,” Siri
writes.
FDA Asks the Court to Delay First 55,000 Page Production Until May and Pfizer Moves to Intervene in the Lawsuit
Somewhere on the other side of the growing heap of government and pharma lawyers is transparency.
aaronsiri.substack.com
As the FDA tries to obtain months of delay, guess who just showed upon in the lawsuit? Yep, Pfizer. And it is represented by a global chair and team from a law firm with thousands of lawyers. Pfizer’s legal bill will likely be multiple times what it would cost the FDA to simply hire a private document review company to review, redact, and produce the documents at issue. Within weeks, if not days.
Pfizer is coming in as a third party. But Pfizer assures the Court it is here to help expedite production of the documents. Sure it is! Where was Pfizer before the Court ordered the 55,000 pages per month? Right, doing what it normally does: letting the government work on its behalf – like the way the government mandates, promotes, and defends Pfizer’s product.
V copy/paste času bi morali ta pdf postali v 1 minuti...
nekaj drobnega tiska o Pfizer cepivu
Aaron, I'm extremely grateful for what you are doing. As an independent scientist, this is UNACCEPTABLE! From the Australian Nonclinical Evaluation Report and the biodistribution study: “Parturition: One ~ in the BNT162b3 group was euthanised on LDl showing hunched posture, pale, marked...
aaronsiri.substack.com
From the Australian Nonclinical Evaluation Report and the biodistribution study:
“Parturition: One ~ in the BNT162b3 group was euthanised on LDl showing hunched posture, pale, marked piloerection, bleeding at the vulva, distended/purple abdomen. One ~ each in the BNT162bl and BNT162b3 groups were euthanised due to all stillborn pups or total litter death. No macroscopic findings were noted in maternal necropsy.”
Fetal malformations/variations were found in the pups of dams in the treatment groups.
Also of concern:
Genotoxicity
No genotoxicity studies were conducted for the vaccine
Carcinogenicity
Carcinogenicity studies were not conducted.
2-[(Polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159) and ((4-
hydroxybutyl)azanediyl) bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315) are novel excipients
and are not listed on the TGA' s ingredient database.
ALC-0315 (the ester formulation) was minimally metabolized and only 1% was excreted
ALC-0159 (the amide formulation) was more completely metabolized and only 50% was excreted
These novel LNP have very long elimination half-lives, especially ALC-0315 (the ester formulation), which is extremely concerning.
These data prove that the LNP are distributed systemically, not broken down efficiently, and stay in the body for a long period of time. Not only that, but the spike (S) protein expression can occur anywhere in the body, reaches high levels of expression, and may be of long duration (possibly mimicking the length of time antibody titers remain elevated.)
The biodistribution study is also very alarming because it shows that these LNPs accumulate not only at the injection site but also immediately to the liver, spleen, kidneys, and lymph nodes with rising concentrations (at 48 hours, the longest timepoint measured) in the ovaries, bone marrow, thyroid gland, pituitary gland, heart, and lungs. I have not had time to curve fit and mathematically extrapolate the tissue concentrations to further timepoints.
I think that fact was in the Pfizer study materials given to FDA: https://bailiwicknewsarchives.files.wordpress.com/2021/12/2020.11-pfizer-biontech-c4591001-clinical-protocol.pdf P. 72 - no pharmacokinetics, no pharmacodynamics, no genetics, no bio markers Japan bio distribution study Byram...
aaronsiri.substack.com
I think that fact was in the Pfizer study materials given to FDA:
https://bailiwicknewsarchives.files...fizer-biontech-c4591001-clinical-protocol.pdf
P. 72 - no pharmacokinetics, no pharmacodynamics, no genetics, no bio markers
Japan bio distribution study Byram Bridle got in Spring 2021 included some of those:
https://pandemictimeline.com/wp-con...nfidential-document-translated-to-english.pdf